Table 3. Kaplan–Meier survival analysis: Carcinoma-specific survival in ovarian carcinomas according to clinico-pathological factors and VEGF-C, VEGF-D or VEGFR-3 detection.

Variable	No. of patients	10-year survival rate (%)	χ2	Logrank P-value
VEGF-C			3.956	0.046
Negative	20	79.2
Positive	39	40.1
VEGF-D			9.365	0.002
Negative	22	85.1
Positive	37	30.2
VEGFR-3			2.282	0.13
Negative	23	69.5
Positive	36	22.7
Peritoneal metastasis outside the pelvis			23.524	<0.0001
Negative	39	75.2
Positive	20	Not reached
Lymph node metastasis			25.372	<0.0001
Negative	44	69.1
Positive	15	9.7
Distant metastasis			1.707	0.19
Negative	55	50
Positive	4	50
Age			4.736	0.03
⩽60	37	56.2
60	22	36.1
Histological type			1.789	0.18
Serous	32	31.6
Nonserous	27	63.3
Histological grade			3.669	0.055
Well	36	69.8
Moderate and poor	23	Not reached